Davis's drug guide for nurses, 15th edition (Record no. 30098)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04402nam a2200445 i 4500 |
| 001 - CONTROL NUMBER | |
| control field | FADAVISB0000563 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m eo d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cn |||m|||a |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200328s2016 ob 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0803657056 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0803660790 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780803657052 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780803657793 |
| 041 0# - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM301.12 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.1024613 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Vallerand, April Hazard. |
| 245 10 - TITLE STATEMENT | |
| Title | Davis's drug guide for nurses, 15th edition |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | April Hazard Vallerand, Cynthia A. Sanoski, Judith Hopfer Deglin. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 15th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | [Place of publication not identified] : |
| Name of publisher, distributor, etc. | F.A. Davis Company, |
| Date of publication, distribution, etc. | 2016. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | [Place of publication not identified] : |
| Name of producer, publisher, distributor, manufacturer | F.A. Davis Company, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2016. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (1493 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Davis's drug guide for nurses, 15th edition -- DEDICATION\ACKNOWLEDGMENTS -- CONSULTANTS -- F. A. DAVIS PHARMACOLOGIC PUBLICATIONS ADVISORY BOARD -- F.A. DAVIS CANADIAN ADVISORY BOARD -- CONTENTS -- HOW TO USE DAVIS'S DRUG GUIDE FOR NURSES -- EVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: IMPLICATIONS FOR NURSES -- PHARMACOGENOMICS -- MEDICATION ERRORS: IMPROVING PRACTICES AND PATIENT SAFETY -- DETECTING AND MANAGING ADVERSE DRUG REACTIONS -- OVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS) -- SPECIAL DOSING CONSIDERATIONS -- THE CYTOCHROME P450 SYSTEM: WHAT IS IT AND WHY SHOULD I CARE? -- EDUCATING PATIENTS ABOUT SAFE MEDICATION USE -- CLASSIFICATIONS\ANTI-ALZHEIMER'S AGENTS -- ANTIANEMICS -- ANTIANGINALS -- ANTIANXIETY AGENTS -- ANTIARRHYTHMICS -- ANTIASTHMATICS -- ANTICHOLINERGICS -- ANTICOAGULANTS -- ANTICONVULSANTS -- ANTIDEPRESSANTS -- ANTIDIABETICS -- ANTIDIARRHEALS -- ANTIEMETICS -- ANTIFUNGALS -- ANTIHISTAMINES -- ANTIHYPERTENSIVES -- ANTI-INFECTIVES -- ANTINEOPLASTICS -- ANTIPARKINSON AGENTS -- ANTIPLATELET AGENTS -- ANTIPSYCHOTICS -- ANTIPYRETICS -- ANTIRETROVIRALS -- ANTIRHEUMATICS -- ANTITUBERCULARS -- ANTIULCER AGENTS -- ANTIVIRALS -- BETA BLOCKERS -- BONE RESORPTION INHIBITORS -- BRONCHODILATORS -- CALCIUM CHANNEL BLOCKERS -- CENTRAL NERVOUS SYSTEM STIMULANTS -- CORTICOSTEROIDS -- DIURETICS -- HORMONES -- IMMUNOSUPPRESSANTS -- LAXATIVES -- LIPID-LOWERING AGENTS -- MINERALS/ELECTROLYTES/pH MODIFIERS -- NATURAL/HERBAL PRODUCTS -- NONOPIOID ANALGESICS -- NONSTEROIDAL ANTI-INFLAMMATORY AGENTS -- OPIOID ANALGESICS -- SEDATIVE/HYPNOTICS -- SKELETAL MUSCLE RELAXANTS -- THROMBOLYTICS -- VACCINES/IMMUNIZING AGENTS -- VITAMINS -- WEIGHT CONTROL AGENTS -- DRUG MONOGRAPHS IN ALPHABETICAL ORDER BY GENERIC NAME -- DRUGS APPROVED IN CANADA -- NATURAL/HERBAL PRODUCTS -- MEDICATION SAFETY TOOLS -- APPENDICES -- APPENDIX A: RECENT DRUG APPROVALS -- APPENDIX B: COMBINATION DRUGS -- APPENDIX C: OPHTHALMIC MEDICATIONS -- APPENDIX D: MEDICATION ADMINISTRATION TECHNIQUES -- APPENDIX E: FORMULAS HELPFUL FOR CALCULATING DOSES -- APPENDIX F: NORMAL VALUES OF COMMON LABORATORY TESTS -- APPENDIX G: PREGNANCY CATEGORIES -- APPENDIX H: CONTROLLED SUBSTANCES SCHEDULES -- APPENDIX I: EQUIANALGESIC DOSING GUIDELINES -- APPENDIX J: FOOD SOURCES FOR SPECIFIC NUTRIENTS -- APPENDIX K: INSULINS AND INSULIN THERAPY -- APPENDIX L: CANADIAN AND U.S. PHARMACEUTICAL PRACTICES -- APPENDIX M: ROUTINE PEDIATRIC AND ADULT IMMUNIZATIONS -- APPENDIX N: ADMINISTERING MEDICATIONS TO CHILDREN -- APPENDIX O: PEDIATRIC DOSAGE CALCULATIONS -- APPENDIX P: PEDIATRIC FLUID AND ELECTROLYTE REQUIREMENTS -- BIBLIOGRAPHY -- COMPREHENSIVE INDEX. |
| 506 ## - RESTRICTIONS ON ACCESS NOTE | |
| Terms governing access | Access restricted to authorized users and institutions. |
| 520 3# - SUMMARY, ETC. | |
| Summary, etc. | Davis's Drug Guide for Nurses®, Fifteenth Edition delivers all of the information you need to administer medications safely across the lifespan-well-organized monographs for hundreds of generic and thousands of trade-name drugs. |
| 538 ## - SYSTEM DETAILS NOTE | |
| System details note | Mode of access: World Wide Web. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drugs |
| 9 (RLIN) | 34388 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nursing |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical pharmacology |
| 9 (RLIN) | 34389 |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sanoski, Cynthia A., |
| Relator term | author |
| 9 (RLIN) | 25005 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Deglin, Judith Hopfer, |
| Relator term | author |
| 9 (RLIN) | 721 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://portal.igpublish.com/iglibrary/search/FADAVISB0000563.html">https://portal.igpublish.com/iglibrary/search/FADAVISB0000563.html</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | E-book |
No items available.